These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 870274)

  • 21. Hepatic oxidative drug metabolism and the microsomal milieu in a rat model of congenital hyperbilirubinemia.
    Meredith CG; Muhoberac BB; Gray JP; Speeg KV; Dunn D; Hoyumpa AM; Schenker S
    Biochem Pharmacol; 1986 Nov; 35(21):3831-7. PubMed ID: 3778508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
    Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
    Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [14C]Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications.
    Burnstein AV; Galambos JT
    Dig Dis Sci; 1981 Dec; 26(12):1078-83. PubMed ID: 7307854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hyperbilirubinemia in acute inflammation of appendix: a prospective study of 45 cases.
    Khan S
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):281-9. PubMed ID: 18603920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the (14C) aminopyrine breath test in liver disease.
    Galizzi J; Long RG; Billing BH; Sherlock S
    Gut; 1978 Jan; 19(1):40-5. PubMed ID: 624504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride.
    Schoeller DA; Kotake AN; Lambert GH; Krager PS; Baker AL
    Hepatology; 1985; 5(2):276-81. PubMed ID: 3920135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
    Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
    Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of age and sex on the N-demethylation rate of 14C-aminopyrine, studied by the breath test.
    Pirotte J; El Allaf D
    Digestion; 1983; 28(4):210-5. PubMed ID: 6671482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of interference by sorbitol with aminopyrine breath test.
    Ramin VC; Bircher J
    Eur J Clin Pharmacol; 1990; 38(1):87-9. PubMed ID: 2109699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vivo measurement of expired 14CO2 derived from the N-demethylation of aminopyrine as a reflection of the in vitro hepatic cytochrome P-450 drug-metabolism activity in rats.
    Kotake AN; Schreider BD; Latts JR
    Drug Metab Dispos; 1982; 10(3):251-8. PubMed ID: 6125358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The aminopyrine breath test.
    Perri F; Pastore M; Annese V; Andriulli A
    Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease.
    Caspary WF; Schäffer J
    Digestion; 1978; 17(5):410-8. PubMed ID: 680418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different methods expressing results of the aminopyrine breath test.
    Schoeller DA; Baker AL; Monroe PS; Krager PS; Schneider JF
    Hepatology; 1982; 2(4):455-62. PubMed ID: 6807795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatic drug metabolism by norethindrone.
    Field B; Lu C; Hepner GW
    Clin Pharmacol Ther; 1979 Feb; 25(2):196-8. PubMed ID: 759072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A correlation between serum mebendazole concentrations and the aminopyrine breath test. Implications in the treatment of hydatid disease.
    Bekhti A; Pirotte J; Woestenborghs R
    Br J Clin Pharmacol; 1986 Feb; 21(2):223-6. PubMed ID: 3082346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical appraisal of 13C breath tests for microsomal liver function: aminopyrine revisited.
    Pijls KE; de Vries H; Nikkessen S; Bast A; Wodzig WK; Koek GH
    Liver Int; 2014 Apr; 34(4):487-94. PubMed ID: 24428683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.
    Reichen J; Arts B; Schafroth U; Zimmermann A; Zeltner B; Zysset T
    Gastroenterology; 1987 Oct; 93(4):719-26. PubMed ID: 3623018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction.
    Fan ST; Wang QS; Lo CM; Tam Yu KW; Lai EC; Wong J
    Aust N Z J Surg; 1994 Nov; 64(11):759-62. PubMed ID: 7945083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.